Rejoyn Wants to Treat Your Depression Digitally, Experts Aren’t Sure
Rejoyn, the first digital prescription app for major depressive disorder, was just cleared by the US Food and Drug Administration. Approval is based on the data from a 13-week trial of 389 participants, which found that those who used Rejoyn had an improvement in depression symptom severity. Depression is one of the most common mental … Read more